Skip to main content
Premium Trial:

Request an Annual Quote

Benitec, Biomics to Collaborate on Expressed RNAi Rx for HBV

Premium

Benitec announced this week that it has agreed to collaborate with Chinese biopharmaceutical shop Biomics Biotechnologies on the development of an expressed RNAi-based treatment for chronic hepatitis B infection.

Benitec said the companies first intend to develop a "project plan for target identification and validation." Once a target has been selected, it will advance through preclinical and clinical testing.

The companies will share all intellectual property arising from the partnership and will jointly develop and commercialize the resulting HBV drug, Benitec said. Additional terms were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.